Quick look at Big Pharma’s U.S. rap sheet
Recent turbulence in China for drug makers follows big problems for members of the industry in the United States, where they’ve paid billions in criminal fines and civil penalties.
Here’s a quick rundown of their U.S.… Continue Reading